Second instance of canine coronavirus found in a person
UF researchers report an uncommon instance of a past infection in an adult by a dog coronavirus strain that also contained genetic features of a cat coronavirus.
UF researchers report an uncommon instance of a past infection in an adult by a dog coronavirus strain that also contained genetic features of a cat coronavirus.
Compared with the U.S., why are some countries less affected by COVID-19? A UF researcher leads a team looking for answers in Africa. “If we can learn what can protect us as a species, we could potentially be better prepared for the next pandemic," said Rhoel Dinglasan, professor of infectious diseases.
A team of UF researchers report genetic sequencing evidence showing how the gamma (P.1) variant rapidly replaced earlier lineages of the SARS-CoV-2 virus this past summer in Haiti. The outbreak occurred despite a relatively high level of immunity to SARS-CoV-2 within the population.
A new study found that 35% of all COVID-19 cases are asymptomatic. Children are most likely to lack symptoms, while the elderly are least likely.
A team of UF researchers has identified dozens of novel therapeutic targets for the development of antiviral therapies against COVID-19 and other coronaviruses that infect people.
A multidisciplinary team of scientists will study how wildfire smoke spreads fungi that can affect human health, using artificial intelligence to predict future threats.
University of Florida researchers identify first known instances of two different types of viruses in Haitian children. The work marks the first time that Melao virus has been found in humans and the first time that both Melao and Oropouche viruses have been found in Haiti.
A UF infectious disease expert underscores a call for research into connections between the gut microbiome and health inequities.
New work by a UF biologist uses mobility data and genetic sequencing to reconstruct how dengue viruses circulate within Thailand.
UF’s EPI is partnering with Gainesville-based tech company SurfPlasma, Inc. to test a new device’s ability to kill pathogens — even the celestial kinds.